MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Skin in the game: Small fiber neuropathy in Parkinson’s disease and atypical parkinsonisms.

    R. Infante, G. Rizzo, A. Incensi, C. Scaglione, S. Capellari, V. Donadio, R. Liguori (Bologna, Italy)

    Objective: The aim of our study was to compare somatic and autonomic small fiber density, through skin biopsy, in Parkinson's disease (PD) and atypical parkinsonisms…
  • 2019 International Congress

    A case of osmotic demyelination syndrome presenting parkinsonism affected by blood alcohol concentration change

    M. Kondo, A. Unaki, T. Kimura (Tokyo, Japan)

    Objective: To describe a patient with osmotic myelinolysis caused by change in blood alcohol level who developed acute parkinsonism. Background: Osmotic myelinolysis is an acute,…
  • 2019 International Congress

    STN-DBS programing for dyskinesia: a case report

    L. Li, Y. Zhang (Beijing, China)

    Objective: To investigate the effect of STN stimulation on different types of dyskinesia and programming strategy. Background: Long-term use of levodopa or dopamine agonists often…
  • 2019 International Congress

    The long-term effect of continuous apomorphine treatment on camptocormia in Parkinson´s disease: a 24-months longitudinal open, prospective follow-up study

    K. Mensikova, M. Kaiserova, M. Vastik, M. Nevrly, S. Kurcova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: The aim of the study was to assess the long-term effect of subcutaneous infusions of apomorphine in the treatment of camptocormia in advanced Parkinson's…
  • 2019 International Congress

    Parkinsonian syndrome associated to C9orf72 expansion

    S. Novo Ponte, E. Gamo González, P. Sánchez Alonso (Majadahonda, Spain)

    Objective: To describe a case of parkinsonian syndrome associated to C9Orf72 expansion followed by ALS development Background: C9Orf72 expansions are known to be the most…
  • 2019 International Congress

    Deep Brain Stimulation Wash-in/out Periods Quantified using a Palm-Worn Device to Monitor Rigidity

    T. Perera, WL. Lee, M. Jones, J. Tan, E. Proud, A. Begg, N. Sinclair, R. Peppard, H. Mcdermott (East Melbourne, Australia)

    Objective: Characterize the temporal resurgence/amelioration of Parkinsonian rigidity corresponding to withdrawal/application of deep brain stimulation (DBS) therapy. Background: Rigidity is a cardinal symptom of Parkinson’s…
  • 2019 International Congress

    Pharmacokinetics of ABBV-951 Following 24-Hour Continuous Subcutaneous Infusion to Arm, Abdomen and Thigh

    M. Rosebraugh, P. Kym, W. Liu, M. Facheris, J. Benesh (North Chicago, IL, USA)

    Objective: Characterize levodopa pharmacokinetics (PK) and safety/tolerability of ABBV-951 in healthy volunteers at 3 different subcutaneous (SC) infusion sites: Arm, Abdomen and Thigh Background: As…
  • 2019 International Congress

    Resting-state EEG functional connectivity in Parkinson’s disease

    R. Shoorangiz, E. Peterson, R. Jones, L. Livingston, I. Kirk, L. Tippett, M. Livingstone, T. Anderson, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To examine EEG functional connectivity (FC) between brain regions during resting wakefulness as a function of cognitive status in PD. Background: Progressive cognitive decline…
  • 2019 International Congress

    Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study

    V. Suarez Contreras, Y. Tayyabah, S. Caminiti, M. Politis (London, United Kingdom)

    Objective: Evaluate the association between drooling and striatal dopamine terminals. Test the assumption that drooling correlates with disease progression in de novo Parkinson’s disease (PD)…
  • 2019 International Congress

    Association between quality of life and physical functions in patients with idiopathic Parkinson’s disease

    BO. Ugut, T. Kahraman, AC. Kalkan, B. Donmez Colakoglu, A. Genc (Izmir, Turkey)

    Objective: The aim was to investigate the association between health-related quality of life and physical functions in the patients with idiopathic Parkinson's disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 157
  • 158
  • 159
  • 160
  • 161
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley